University of Bristol, Imperial College London UK Prof. Lourdes Agapito Synthesia Novel AI University College London UK Prof. Allan Bradley Kymab, T-Therapeutics, PetMedix, Lexicon Pharmaceuticals Life Sciences Wellcome Trust Sanger Institute, University of Cambridge UK Prof. Pedro Bizarro, Prof. Paulo Marques Feedzai AI University of Coimbra Portugal Dr. Chris Ballance, Dr. Thomas Harty Oxford Ionics Quantum University of Oxford UK Dr. Dragan Grabulovski, Dr. Philipp Spycher Araris Biotech Life Sciences ETH Zurich, Paul Scherrer Institut Switzerland Prof. Thomas Thum, Dr. Claudia Ulbrich Cardior Pharmaceuticals Life Sciences Medizinische Hochschule Hannover, Max Planck Germany Name Spinouts Sector Institute Country Dr. Tej Tadi MindMaze Medical Devices EPFL Switzerland Dr. Alexander [...] largest VC rounds in Deep Tech and Life Sciences spinouts in 2025 show a strong focus on AI & Autonomy, Quantum, Space, Medical Devices and Life Sciences, and Nuclear energy AI video generation University College London (UCL) $380M Series D + Late VC - Jan & Oct 2025 Protein-drug conjugation LMU, Leibniz €308M Series C - Oct 2025 Superconducting quantum computers Aalto University, VTT $320M Series B - Sep 2025 Advanced unmanned aerial vehicles Bundeswehr University Munich €160M Series C - May 2025 Next generation space launch rockets TU Munich €150M Convertible - Jun 2025 Organ perfusion system for liver transplantation University of Oxford $160M Growth Equity VC - Feb 2025 Rare disease the
Access investment thesis, focus areas, bio, and contact details for Dr Alexander Stage and 22,000+ other VC professionals.
Berlin, DE